Inari Medical, Inc. (NASDAQ: NARI) reported Q4 EPS of $0.02, $0.01 worse than the analyst estimate of $0.03. Revenue for the quarter came in at $83.2 million versus the consensus estimate of $78.16 million.

For earnings history and earnings-related data on Inari Medical, Inc. (NARI) click here.